ECM
TMCI icon

ExodusPoint Capital Management’s Treace Medical Concepts TMCI Stock Holding History

ExodusPoint Capital Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-27,893
Closed -$234K – 1973
2025
Q1 		$234K Sell
27,893
-5,828
-17% -$52.4K ﹤0.01% 1272
2024
Q4 		$251K Buy
+33,721
New +$226K ﹤0.01% 1324
2024
Q2 		– Sell
-55,498
Closed -$724K – 1983
2024
Q1 		$724K Buy
+55,498
New +$740K 0.01% 1047
2023
Q3 		– Sell
-15,543
Closed -$398K – 2142
2023
Q2 		$398K Buy
15,543
+376
+2% +$9.71K ﹤0.01% 1439
2023
Q1 		$382K Buy
+15,167
New +$356K ﹤0.01% 1409

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ExodusPoint Capital Management's TMCI Position: Q2 2025 in Review

ExodusPoint Capital Management sold out of Treace Medical Concepts (TMCI) in Q2 2025, closing a stake of 27,893 shares — an estimated $234K sold.

ExodusPoint Capital Management first reported a position in TMCI in Q1 2023 and held it in 5 quarters. The position peaked at $724K in Q1 2024. 125 funds tracked by Wall St. Rank hold TMCI as of Q2 2025.

  • ExodusPoint Capital Management reported no remaining Treace Medical Concepts position as of Q2 2025 after selling out during the quarter.
  • ExodusPoint Capital Management sold 27,893 Treace Medical Concepts shares in Q2 2025, an estimated $234K.
  • ExodusPoint Capital Management first reported a position in Treace Medical Concepts in Q1 2023 and held it in 5 quarters.
  • ExodusPoint Capital Management's Treace Medical Concepts position peaked at $724K in Q1 2024.
  • 125 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2025.

Based on ExodusPoint Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.